Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2013 | 09-2012 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,028 | 59 |
| Other current assets | 3,074 | 877 |
| TOTAL | $4,999 | $1,254 |
| Non-Current Assets | ||
| PPE Net | 328 | 296 |
| Intangibles | 309 | 309 |
| TOTAL | $637 | $605 |
| Total Assets | $5,636 | $1,859 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 2,000 | 0 |
| Accounts payable and accrued liabilities | 1,443 | 647 |
| TOTAL | $4,860 | $1,222 |
| Non-Current Liabilities | ||
| Long Term Debt | 0 | 1,700 |
| TOTAL | $0 | $1,700 |
| Total Liabilities | $4,860 | $2,922 |
| Shareholders' Equity | ||
| Common Shares | 6 | 4 |
| Retained earnings | -7,299 | -4,107 |
| Other shareholders' equity | 138 | 0 |
| TOTAL | $776 | $-1,063 |
| Total Liabilities And Equity | $5,636 | $1,859 |